Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A rapid, blood-based triage test that allows targeted investigation for tuberculosis at the point of care could shorten the time to tuberculosis treatment and reduce mortality. We aimed to test the performance of a host blood transcriptomic signature (RISK11) in diagnosing tuberculosis and predicting progression to active pulmonary disease (prognosis) in people with HIV in a community setting.

More information Original publication

DOI

https://doi.org/10.1016/S2214-109X(21)00045-0

Type

Alumni publications

Publisher

The Lancet

Publication Date

13/04/2021

Volume

9

Keywords

HIV/AIDS, Tuberculosis , mycobacterial infections,